Andrew Sauter

Mr. Sauter has an exceptional record in driving sustained growth through advancing corporate strategies for innovative products and research and development. He excels in technical accounting and financial operations, with a proven track record of financial integrity and cultivating investor relationships.

​

Prior to LifeMax, Mr. Sauter served as Chief Financial Officer of Sera Prognostics, where he provided strategic direction as the company raised multiple rounds of capital from venture, strategic and private equity investors to build a CLIA-certified reference lab and validate a biomarker test for preterm birth and other pregnancy complications. Prior to Sera, Mr. Sauter served as Chief Financial Officer of Avigen, Inc. (NASDAQ: AVGN), a biopharmaceutical company that focused on the development of innovative drugs for the treatment of serious and chronic neurological conditions.

​

Earlier in his career, Mr. Sauter worked for Bank of America Corporation in a variety of positions, including as vice president in the Capital Markets Finance organization, and for Ernst & Young LLP as an auditor. Mr. Sauter is an inactive certified public accountant and holds a B.A. degree in economics and accounting from Claremont McKenna College.